Q3 2019

Filed Oct 30, 2019 · 10-Q · 30 days after period end · 0001104506-19-000026

Q3 2019 · 10-Q

Revenue

$38.89M

— vs Q3 2018

Net Income

-$60.68M

N/M vs Q3 2018

EPS Diluted

-$0.68

N/M vs Q3 2018

Gross Profit$32,448,000—

Operating Income

Same quarter

Metric	Q3 2019	Q3 2018	Q3 2017	Q3 2016
Revenue	$38.89M	$0.00	$0.00	$0.00
Net Income	-$60.68M	-$87.74M	-$45.18M	-$37.76M
EPS Diluted	-$0.68	-$1.14	-$0.69	-$0.61

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR